Elmiron Lawsuit [2026 Update] | Elmiron Vision Loss Claims

The Elmiron Lawsuit involves claims that the bladder medication Elmiron has caused serious vision problems, including maculopathy and irreversible vision loss.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn patients and healthcare providers of these risks.

63 cases were dismissed from the Elmiron MDL in the past month.

Vision loss linked to Elmiron can have long-term consequences, significantly impacting daily life and overall well-being.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit experienced a decrease in the number of new filings between March and April 2025.

In March, the litigation contained a total of 1,273 cases.

By April, this number dropped to 1,091, a reduction of 182 new cases.

The Elmiron Lawsuit involves individuals who have suffered vision damage allegedly linked to long-term use of the drug Elmiron, which is prescribed to treat interstitial cystitis (IC).

Patients have reported various eye issues, including maculopathy, a condition that can lead to permanent vision loss.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit involves claims that the bladder medication Elmiron has caused severe vision issues, including maculopathy and permanent vision loss.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn patients and healthcare providers about these risks.

In February, 1,339 cases were pending in the Elmiron MDL.

The number of Elmiron Lawsuits has decreased to 1,273 in March, a reduction of 66 cases.

This decline may be due to case consolidations or procedural adjustments within the litigation.

Elmiron-related vision damage can have long-term consequences, affecting daily activities and quality of life for those impacted.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit involves claims that the bladder medication Elmiron has caused severe vision issues, including maculopathy and permanent vision loss.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn patients and healthcare providers about these risks.

In January, 1,389 cases were filed, decreasing to 1,339 in February, reflecting a reduction of 50 cases.

Elmiron-related vision damage can have long-term consequences, affecting daily activities and quality of life for those impacted.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit involves claims that the bladder medication Elmiron has caused severe vision issues, including maculopathy and permanent vision loss.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn patients and healthcare providers about these risks.

In December, 1,433 cases were pending in the Elmiron MDL

The number of pending cases has decreased to 1,389 in January, reflecting a reduction of 44 cases.

Vision complications linked to Elmiron can have lasting impacts on daily life, often resulting in irreversible damage for affected individuals.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Vision Loss lawsuit involves claims that the bladder medication Elmiron has caused severe vision problems, including maculopathy and permanent vision loss.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn of these risks.

In November, 1,438 cases were filed, decreasing slightly to 1,433 in December, a drop of 5 cases.

This decrease may reflect case consolidations or procedural adjustments.

Elmiron-related vision issues can severely impact daily life, with many patients experiencing irreversible damage.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Vision Loss lawsuit focuses on claims that the drug Elmiron, prescribed for interstitial cystitis, has led to severe vision problems, including maculopathy, a retinal disease causing vision impairment.

Plaintiffs allege that Janssen Pharmaceuticals failed to adequately warn of the risks leading to permanent vision damage for many patients.

In October, there were 1,449 cases filed in connection with Elmiron vision loss claims.

By November, this number slightly decreased to 1,438, a reduction of 11 cases.

Elmiron is linked to severe eye damage, with many patients reporting difficulty reading, adjusting to low light, and other visual impairments that can dramatically affect daily life.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Vision Loss lawsuit centers on claims that the drug Elmiron, prescribed for interstitial cystitis (a chronic bladder condition), is linked to vision damage and eye disorders.

Patients allege that the drug’s manufacturer, Janssen Pharmaceuticals, failed to adequately warn them about the potential for serious eye problems, including maculopathy, a degenerative disease of the retina, leading to permanent vision loss in many cases.

In September, 1,454 cases were filed in the Elmiron Vision Loss lawsuit.

By October, the number slightly decreased to 1,449. 

The decrease in cases might reflect the consolidation of claims as new information emerges, but the total number still represents a significant portion of affected patients who are pursuing legal action for their injuries.

Elmiron has been linked to serious vision issues, with many patients reporting difficulty reading, adapting to dim lighting, and other vision problems.

The drug is alleged to cause damage to the retinal cells, resulting in permanent vision impairment.

These issues can severely impact quality of life, as many patients who relied on Elmiron to manage bladder pain are now facing irreversible eye damage.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Vision Loss Lawsuit decreased slightly in filings from 1,457 in August to 1,454 in September.

Elmiron, a medication prescribed for interstitial cystitis, has been linked to serious vision-related side effects, including maculopathy and other forms of retinal damage.

Many patients have reported experiencing permanent vision loss or significant impairment after prolonged use of the drug.

As awareness of these risks has grown, so too has the number of lawsuits filed against the manufacturer, Janssen Pharmaceuticals.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit involves claims against Janssen Pharmaceuticals regarding the drug Elmiron, which is prescribed for interstitial cystitis.

Plaintiffs allege that Elmiron causes serious vision problems, including maculopathy and other retinal issues.

In July, there were 1,588 Elmiron Lawsuits pending in the MDL.

By August, this number decreased to 1,457 filings.

This decrease may be due to confidential case settlements, reducing the overall number of active filings as some plaintiffs have resolved their claims.

Elmiron has been linked to vision damage, particularly maculopathy, a condition affecting the central part of the retina.

This can lead to vision loss and other serious eye conditions.

Affected individuals have filed lawsuits against Janssen Pharmaceuticals for failing to adequately warn about these risks.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

Our Elmiron lawyers are still accepting cases from those who have experienced vision issues subsequent to using Elmiron, a drug used to treat interstitial cystitis.

Elmiron Lawsuits primarily involve claims of maculopathy, retinal damage, and other severe vision impairments resulting from prolonged use of the drug.

The core arguments in the Elmiron Vision Loss lawsuits revolve around: 

• Failure to Warn: Plaintiffs argue that the manufacturer did not provide adequate warnings about the potential risk of vision loss associated with Elmiron.
• Negligent Manufacturing: Allegations include that manufacturing flaws in Elmiron contribute to the drug’s harmful side effects.
• Negligent Testing: Claims suggest that insufficient testing was conducted to understand the long-term impacts of Elmiron on vision health.

In response to the increasing litigation, healthcare professionals recommend the following precautions for those using Elmiron: 

• Regular Eye Exams: Schedule frequent eye exams to detect any early signs of vision issues.
• Report Symptoms Promptly: Immediately inform your healthcare provider if you notice any changes in your vision.
• Consider Alternatives: Discuss with your doctor about potential alternative treatments for your condition.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Vision Loss lawsuit involves claims that the bladder medication Elmiron causes significant vision damage, including retinal injury and vision loss.

This lawsuit seeks to hold the manufacturer accountable for these serious side effects.

In June, there were 1,750 Elmiron Vision Loss lawsuit filings.

By July, this number decreased to 1,588.

Elmiron causes vision loss by damaging the retina, leading to conditions such as maculopathy, which results in blurred vision, difficulty reading, and even blindness.

These severe impacts have prompted more individuals to join the Elmiron Vision Loss lawsuit.

The Elmiron Vision Loss lawsuit aims to hold the manufacturer responsible for the harm caused by the drug.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

The Elmiron Lawsuit addresses allegations that the long-term use of the prescription drug Elmiron, used to treat interstitial cystitis, leads to significant eye damage, specifically pigmentary maculopathy.

There was a decrease in Elmiron lawsuit filings, from 1,829 reported on May 1st to 1,750 reported on June 3rd.

This reduction of 79 cases can be attributed to confidential settlements as the multidistrict litigation (MDL) progresses.

Recent developments in the Elmiron MDL include the cancellation of a settlement conference by Judge Martinotti, originally scheduled for May 13, which has not yet been rescheduled.

Individuals affected by Elmiron have reported severe vision problems, including difficulty adapting to low light, blurred vision, and complete vision loss, which are symptoms of pigmentary maculopathy.

Despite the decrease in active cases, our Elmiron lawsuit lawyers continue to accept new cases.

It is essential for anyone experiencing complications from Elmiron to consult with a qualified lawyer to understand their legal rights and options.

If you or a loved one took Elmiron and experienced vision problems or other side effects, you may be eligible to file an Elmiron Lawsuit.

Contact an experienced Elmiron Lawyer from TorHoerman Law for a free consultation.

Use the chatbot on this page to find out if you qualify for the Elmiron Lawsuit instantly.

Elmiron, used to treat interstitial cystitis, has been linked to significant eye damage.

Janssen Pharmaceuticals, the manufacturer of Elmiron, is accused of not warning about the risks of vision loss.

Elmiron is potentially toxic to the retina, the light sensing tissue at the back of the eye that allows us to see.

Continuous exposure to the drug can lead to a condition known as “pigmentary maculopathy”, which specifically affects the retina and can deteriorate vision over time.

The exact mechanism by which Elmiron causes this damage is not fully understood, but it is believed to disrupt the pigmented cells in the retina.

The pigmented cells in the retina are crucial for absorbing light, recycling visual pigments, transporting nutrients, and removing waste to support overall eye health and function.

Thousands of Elmiron Lawsuits claim severe vision impairments.

Those suffering from symptoms such as blurred vision, difficulty with dim lighting, or dark spots are encouraged to consult our Elmiron lawyers immediately.

Potential settlements in the Elmiron Lawsuit may range between $10,000 to over $600,000 per person depending on individual circumstances and the direction of the litigation as a whole.

Contact TorHoerman Law today to learn more about the Elmiron Lawsuit and your legal options.

You can also use the chatbot on this page to find out if you qualify for an Elmiron Lawsuit instantly.

According to the most recent Judicial Panel on Multidistrict Litigation (JPML) filings, there are 1,829 Elmiron Lawsuits pending.

Elmiron Lawsuits allege that Janssen Pharmaceuticals, the manufacturer, failed to provide adequate warnings to patients and healthcare providers about the risk of vision-related side effects associated with the drug.

If you or a loved one has experienced vision problems after taking Elmiron, contact us today for a free consultation. 

Use the chatbot on this page for an instant case evaluation to find out if you qualify for the Elmiron Lawsuit. 

According to the latest JPML filings, the number of Elmiron Lawsuits consolidated into multidistrict litigation has slightly decreased, standing at 1,835 as of April 1st,

The number of cases is down from 1,865 reported on March 1st.

This decrease can be attributed to some cases being resolved.

Our legal team is continuing to accept new cases related to injuries suffered from Elmiron.

Elmiron, a prescription medication widely used for the treatment of interstitial cystitis (a bladder condition), has been linked to serious eye problems, including a unique type of maculopathy (retinal damage) that can lead to vision loss.

Patients who have used Elmiron and experienced visual impairment have pursued legal action, claiming that the manufacturer failed to provide adequate warnings about the potential risks of eye damage.

For individuals who have experienced adverse effects possibly related to Elmiron use, it may be advisable to explore legal options.

Our firm is here to offer a free consultation for those affected.

You can reach out to TorHoerman Law directly or use the chatbot on our page for immediate assistance.

As per the latest JPML filings, the total number of pending Elmiron lawsuits has seen a decrease, falling to 1,865 cases pending, indicating a reduction of 46 cases.

This shift is largely due to the settlement of multiple individual lawsuits.

Elmiron lawsuits are associated with claims that the drug Elmiron, commonly used to treat interstitial cystitis, has caused significant eye damage and vision loss in patients.

These cases have been consolidated into a Multidistrict Litigation (MDL), a legal procedure designed to streamline the litigation process for numerous related civil lawsuits.

Settlement of these cases has contributed to a decline in the total number of pending lawsuits.

This development is an important one as it signifies progress in resolving the multitude of cases.

It also underscores the potential for individuals who have suffered due to Elmiron to gain compensation for their losses.

The resolution of these cases shows the importance of legal support for individuals who have been adversely affected by such products.

If you or a loved one have taken Elmiron and suffered from vision loss or other serious side effects, it is important to seek legal counsel immediately. 

Reach out for a free consultation today, or use the chatbot.

As of February 2024, there are a total of 1,911 Elmiron Lawsuits pending consolidation into multidistrict litigation, according to the most recent JPML filings.

Multi-District Litigations (MDLs) are legal procedures in the United States designed to handle multiple related civil lawsuits that involve similar issues, facts, or defendants.

When numerous individuals or entities file lawsuits related to a common set of circumstances, such as product liability, pharmaceuticals, or mass tort cases, these cases can be consolidated into a single federal district court for pretrial proceedings.

MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

If you or a loved one took Elmiron and subsequently suffered vision loss, blindness, or any other eye injury linked to the prescription drug, contact the Elmiron Lawyers from TorHoerman Law.

Reach out to us today for a free consultation to learn how we can help you.

Want to find out if you qualify for a lawsuit right away? 

Use our chatbot below for a free case evaluation.

Currently, there are a total of 1,916 filings in the Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation, according to the most recent JPML filings published on January 2nd.

The Elmiron Lawsuit is consolidated into multidistrict litigation (MDL), a type of special legal procedure designed to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

When numerous individuals or entities file lawsuits related to a common set of circumstances, such as product liability, pharmaceuticals, or mass tort cases, these cases can be consolidated into a single federal district court for pretrial proceedings.

In the case of the Elmiron Lawsuit, individuals across the country were prescribed the drug and suffered vision loss as a result, meaning that these cases share common factual questions about the medication’s safety, manufacturing processes, and potential negligence of the manufacturer.

If you or a loved one took Elmiron and subsequently suffered vision loss, blindness, or any other eye injury linked to the prescription drug, contact the Elmiron Lawyers from TorHoerman Law.

Reach out to us today for a free consultation to learn how we can help you.

Want to find out if you qualify for a lawsuit right away? 

Use our chatbot below for a free case evaluation.

The Elmiron Lawsuit saw a decrease of four cases within the MDL over the past month.

This represents the first instance of a monthly reduction in pending cases, resulting in a remaining total of 1,916 cases.

A number of plaintiffs with pending cases have chosen to accept Elmiron settlements, with the understanding that their cases will be dismissed upon finalization of said settlement agreement.

The Elmiron lawsuit is open and we are still accepting cases.

If you or a loved one took Elmiron and subsequently suffered vision loss, blindness, or any other eye injury linked to the prescription drug, contact the Elmiron Lawyers from TorHoerman Law.

Reach out to us today for a free consultation to learn how we can help you.

Want to find out if you qualify for a lawsuit right away? 

Use our chatbot below for a free case evaluation.

The Elmiron MDL currently has 1,915 pending cases, marking a decrease from the 1,925 cases that were pending three months ago.

Our Elmiron Lawyers expect the number of cases consolidated in the Elmiron MDL to decrease as more plaintiffs are offered settlements.

Progress in the Elmiron Lawsuit has become more gradual as settlements are being finalized.

If you or a loved one took Elmiron and subsequently suffered vision loss, blindness, or any other eye injury linked to the prescription drug, contact the Elmiron Lawyers from TorHoerman Law.

Reach out to us today for a free consultation to learn how we can help you.

Want to find out if you qualify for a lawsuit right away? 

Use our chatbot below for a free case evaluation.

Jaansen, the defendant in the ongoing Elmiron litigation, has stalled the three bellwether trials due to recent demonstrations that the company is interested in settling a large number of cases.

All three bellwether trials were scheduled to start between January and March 2023, and they have been halted since July.

Bellwether trials take a few specific cases and mitigate them early — the results of these trials are then used to predict the outcomes of the rest of the cases in the MDL.

If you or a loved one took Elmiron and subsequently suffered vision loss, blindness, or any other eye injury linked to the prescription drug, contact the Elmiron Lawyers from TorHoerman Law.

Reach out to us today for a free consultation to learn how we can help you.

Want to find out if you qualify for a lawsuit right away? Use our chatbot below for a free case evaluation.

Our Elmiron Lawyers are still speaking to potential clients to assess their eligibility to file an Elmiron Lawsuit. 

The Elmiron Lawsuit is making its way toward potential settlement offers, and our lawyers estimate that the Elmiron Lawsuit may be settled in 2023.

The third Elmiron bellwether trial is scheduled for this month (May 2023).

Bellwether trials will help to determine average Elmiron settlement amounts.

There are nearly 2,000 Elmiron Lawsuits currently consolidated in multidistrict litigation (MDL).

The Elmiron MDL (officially titled “Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation”) is consolidated in the US District Court for the District of New Jersey.

MDL is a special federal legal procedure designed to speed the process of handling complex litigations by consolidating cases and addressing all pretrial procedures in one court.

MDLs take cases from multiple federal districts (each state has at least one district), and puts them into one district court.

This single district court, and one judge, then address all the discovery and pretrial procedures that apply to every case – cutting the costs and amount of resources needed, and keeping court rulings consistent with similar cases.

Visit this page for more updates on the Elmiron Lawsuit for eye damage as they become available.

If you or a loved one used Elmiron and subsequently developed vision loss, eye damage, or other vision problems, you may be eligible to file an Elmiron Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for an Elmiron Lawsuit instantly.

The Elmiron Lawsuit is ongoing and lawyers across the country are still accepting clients.

There are nearly 2,000 Elmiron Lawsuits pending in the multidistrict litigation (MDL 2973) in the US District Court for the District of New Jersey.

The court is moving forward with a Case Management Conference on May 10th, 2023.

Then, we may have a better idea of the direction of this litigation and further steps to be taken by the court.

If you or a loved one used Elmiron and subsequently developed vision problems, vision loss, blindness, or other vision-related problems, you may be eligible to file an Elmiron Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for an Elmiron Lawsuit instantly. We’re here to help. 

The Elmiron MDL is growing and our lawyers are accepting cases daily.

Bellwether trials are scheduled for next month, and our attorneys will then have a better idea of what average settlement amounts for Elmiron Lawsuits could be.

If you or a loved one used Elmiron and developed vision problems or other similar injuries, you may be eligible to file a claim.

Contact the Elmiron Lawyers at TorHoerman Law for a free consultation.

You can also use the instant case evaluator to see if you qualify for an Elmiron Lawsuit in less than two minutes.

The Elmiron Lawsuit is ongoing and lawyers across the country are still accepting new clients.

There have been over 1,800 cases consolidated into the Elmiron MDL so far, and more are expected over the coming months.

Bellwether trials are also scheduled for this Spring.

By then, our lawyers may have a better understanding of average settlement amounts for Elmiron lawsuits.

If you or a loved one used Elmiron and subsequently developed vision problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to see if you qualify for an Elmiron Lawsuit instantly.

The Elmiron MDL is nearing 2,000 consolidated cases, and attorneys are preparing for the first bellwether trial at the end of this month.

The bellwether trial will begin the process of uncovering how juries will react to the vision loss claims being made by plaintiffs in the case, and we may get some information on the average settlement amounts for Elmiron Lawsuits.

Visit this page for more updates on the Elmiron Lawsuit as they become available.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify for an Elmiron Lawsuit instantly.

While the pace of new cases being added to the Elmiron MDL has slowed down over the course of 2022, lawsuits are continually being consolidated in US District Court: District of New Jersey.

The first bellwether trial for the Elmiron MDL is set for January 30th, 2023.

Visit this page for more updates on the Elmiron Lawsuit as they become available.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify for an Elmiron Lawsuit instantly.

The Elmiron litigation is ongoing, and lawyers across the country are still accepting new clients and filing claims on their behalf.

The first bellwether trial for the Elmiron multidistrict litigation (MDL 2973) has been pushed back to March 27th, 2023.

Cases are continually being consolidated in the MDL, reaching nearly 2,000 total cases as of this past month.

Visit this page for more updates on the Elmiron MDL as they become available.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify for an Elmiron lawsuit instantly.

The Elmiron litigation is ongoing and lawyers across the country are still accepting clients.

As the last case management order for the Elmiron multidistrict litigation (MDL 2973) indicates, over 1,300 Elmiron cases have been consolidated.

If you or a loved one used Elmiron and were subsequently injured, contact us for a free consultation or use the chatbot on this page to see if you qualify for legal action instantly.

Cases are still being centralized in the Elmiron multidistrict litigation (MDL 2973).

Elmiron bellwether trials are set for early 2023.

Visit this page for more updates on the Elmiron Lawsuit as they become available.

Cases are continuing to be consolidated in the multidistrict litigation (MDL 2973).

Over 300 cases were consolidated into the MDL in the past month, now totaling over 1,300.

The pace of lawsuits being added to the MDL should remain relatively steady over the next few months.

The Elmiron litigation is ongoing and lawyers across the country are still accepting cases.

Over 900 plaintiffs have filed lawsuits and hundreds have been consolidated into the multidistrict litigation located in the US District Court: District of New Jersey (MDL 2973).

The MDL is still proceeding through discovery, and a new date for the “science day” has yet to be rescheduled.

Visit this page for updates on the Elmiron Lawsuit.